JP5706579B2 - リン酸化多糖の製造方法 - Google Patents
リン酸化多糖の製造方法 Download PDFInfo
- Publication number
- JP5706579B2 JP5706579B2 JP2014507863A JP2014507863A JP5706579B2 JP 5706579 B2 JP5706579 B2 JP 5706579B2 JP 2014507863 A JP2014507863 A JP 2014507863A JP 2014507863 A JP2014507863 A JP 2014507863A JP 5706579 B2 JP5706579 B2 JP 5706579B2
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- phosphorylated
- pullulan
- reaction
- alkali compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 20
- 150000004676 glycans Chemical class 0.000 title description 74
- 229920001282 polysaccharide Polymers 0.000 title description 74
- 239000005017 polysaccharide Substances 0.000 title description 74
- 239000003513 alkali Substances 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000007864 aqueous solution Substances 0.000 claims description 25
- 229920001218 Pullulan Polymers 0.000 claims description 21
- 239000004373 Pullulan Substances 0.000 claims description 21
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 21
- 235000019423 pullulan Nutrition 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- -1 phosphorus compound Chemical class 0.000 claims description 16
- 239000011574 phosphorus Substances 0.000 claims description 15
- 229910052698 phosphorus Inorganic materials 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000006227 byproduct Substances 0.000 claims description 5
- 238000009295 crossflow filtration Methods 0.000 claims description 3
- 238000011034 membrane dialysis Methods 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 238000006366 phosphorylation reaction Methods 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 13
- 230000026731 phosphorylation Effects 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000000865 phosphorylative effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000004040 coloring Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- 229920001491 Lentinan Polymers 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 229940115286 lentinan Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- AZSFNUJOCKMOGB-UHFFFAOYSA-K cyclotriphosphate(3-) Chemical compound [O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-K 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 150000003018 phosphorus compounds Chemical class 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000004627 regenerated cellulose Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/02—Esters
- C08B31/06—Esters of inorganic acids
- C08B31/066—Starch phosphates, e.g. phosphorylated starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B33/00—Preparation of derivatives of amylose
- C08B33/02—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0018—Pullulan, i.e. (alpha-1,4)(alpha-1,6)-D-glucan; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
IR分析により行なう。
GPC分析(カラム:TSKgel α−M(東ソー社製)、移動相:0.1M−NaCl水)によって、算出する。
ICP(セイコーインスツルメンツ製VISTA−PRO)により測定して、算出する。
局方プルラン(林原商事社製、数平均分子量30000、白色)20gを水1.5リットル、水酸化ナトリウム19.7gと共に溶解させ、1晩、室温(20℃)にて攪拌した(pH14以上)(アルカリ化合物/多糖=約1/1)。その後、前記溶液を0℃に冷却した後、塩化ホスホリル7.7mL(11.2g)を滴下し、さらに、0℃で6時間攪拌して反応を行った。得られた反応溶液は、再生セルロース膜による透析により、電導度が30μS以下となるまで副生成物のリン酸ナトリウム及び塩化ナトリウムを除去した。次いで、分画分子量5000の限外濾過膜により、クロスフロー濾過を行い、濃縮後、凍結乾燥を行って、リン酸化プルランを得た(収量20g、収率100%)。得られたリン酸化プルランは、IR分析により構造確認し、また、リン酸化度としてリン酸基含有割合が2.8重量%、水酸基の置換割合が6個数%、数平均分子量が約30000、白色であった。
実施例1において、水酸化ナトリウムの使用量を19.7gから200gに変更し(アルカリ化合物/多糖=約10/1)、塩化ホスホリルの使用量を7.7mL(11.2g)から80mL(116g)に変更した以外は、実施例1と同様に反応を行い、リン酸化プルランを得た(収量20g、収率100%)。得られたリン酸化プルランは、IR分析により構造確認し、また、リン酸化度としてリン酸基含有割合が4.7重量%、水酸基の置換割合が10.3個数%、数平均分子量が約50000、白色であった。
内容積2Lのセパラブルフラスコを用いて、実施例1と同じプルラン45.0gを蒸留水205gに室温(20℃)で溶解させた。この溶液を攪拌しながら、1Mのリン酸水溶液(水酸化ナトリウムでpH5.5に調整)1000gを加え、混合した後、水分が9.7%となるまで、全量を加熱真空乾燥した。その後、170℃、5時間加熱してリン酸化プルランを得た(収量25g、収率56%)。得られたリン酸化プルランは、IR分析により構造確認し、また、リン酸化度としてリン酸基含有割合が2.8重量%、水酸基の置換割合が6個数%、数平均分子量が約22000、褐色であった。
実施例1〜2及び比較例1において得られたリン酸化プルランの溶解性を調べた。具体的には、各リン酸化プルランを1gを蒸留水10mLに添加し、攪拌することにより目視で溶解性を確認した。
Claims (6)
- プルラン(a)とアルカリ化合物(b)を含有する水溶液と、オキシ塩化リンを含むリン化合物(c)とを−5〜10℃で混合して反応させることを特徴とするリン酸化プルランの製造方法であって、前記プルラン(a)とアルカリ化合物(b)を含有する水溶液が、プルラン(a)とアルカリ化合物(b)を水に溶解させ、−5〜50℃で攪拌処理したものである、リン酸化プルランの製造方法。
- 反応温度が0〜10℃である請求項1記載の製造方法。
- アルカリ化合物(b)が、水酸化ナトリウムまたは水酸化カリウムである請求項1又は2記載の製造方法。
- アルカリ化合物(b)とプルラン(a)の重量比(b/a)が0.1/1〜20/1である、請求項1〜3いずれか記載の製造方法。
- 反応後の反応混合物を限外濾過膜透析することにより副生成物を除去する請求項1〜4のいずれかに記載の製造方法。
- 反応後の反応混合物の限外濾過膜透析により副生成物を除去した後、さらに限外濾過膜によるクロスフロー濾過により濃縮する請求項5に記載の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014507863A JP5706579B2 (ja) | 2012-03-28 | 2013-03-25 | リン酸化多糖の製造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012073934 | 2012-03-28 | ||
JP2012073934 | 2012-03-28 | ||
JP2014507863A JP5706579B2 (ja) | 2012-03-28 | 2013-03-25 | リン酸化多糖の製造方法 |
PCT/JP2013/058553 WO2013146669A1 (ja) | 2012-03-28 | 2013-03-25 | リン酸化多糖の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP5706579B2 true JP5706579B2 (ja) | 2015-04-22 |
JPWO2013146669A1 JPWO2013146669A1 (ja) | 2015-12-14 |
Family
ID=49259920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014507863A Active JP5706579B2 (ja) | 2012-03-28 | 2013-03-25 | リン酸化多糖の製造方法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5706579B2 (ja) |
WO (1) | WO2013146669A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104017104B (zh) * | 2014-05-20 | 2016-05-25 | 江南大学 | 一种可溶性、高取代度磷酸化酵母葡聚糖的制备方法 |
CA3059529A1 (en) | 2017-04-14 | 2018-10-18 | Capsugel Belgium Nv | Process for making pullulan |
CN110678170A (zh) | 2017-04-14 | 2020-01-10 | 比利时胶囊公司 | 普鲁兰多糖胶囊 |
CN110511297A (zh) * | 2019-10-14 | 2019-11-29 | 武汉华联科生物技术有限公司 | 一种硒香菇多糖的提取分离纯化方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53121887A (en) * | 1977-04-01 | 1978-10-24 | Sumitomo Chem Co Ltd | Preparation of ionic pullulan gel |
JPH04230637A (ja) * | 1990-12-27 | 1992-08-19 | Natl Starch & Chem Investment Holding Corp | タブレット賦形剤としての酵素的に枝切りされたデンプン |
JPH1180201A (ja) * | 1997-09-01 | 1999-03-26 | Kao Corp | 新規多糖誘導体、その製造方法及びそれを含有する化粧料 |
WO2005042587A1 (ja) * | 2003-10-31 | 2005-05-12 | Kowa Co., Ltd. | セルロースiiリン酸エステル及びそれを用いた金属吸着材 |
JP2005519170A (ja) * | 2002-03-08 | 2005-06-30 | ジョージ ウエストン フーズ リミテッド | 架橋されたワキシ小麦デンプン及びこれを含む食品 |
WO2013146668A1 (ja) * | 2012-03-28 | 2013-10-03 | 国立大学法人岡山大学 | リン酸化多糖の固相合成方法 |
-
2013
- 2013-03-25 JP JP2014507863A patent/JP5706579B2/ja active Active
- 2013-03-25 WO PCT/JP2013/058553 patent/WO2013146669A1/ja active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53121887A (en) * | 1977-04-01 | 1978-10-24 | Sumitomo Chem Co Ltd | Preparation of ionic pullulan gel |
JPH04230637A (ja) * | 1990-12-27 | 1992-08-19 | Natl Starch & Chem Investment Holding Corp | タブレット賦形剤としての酵素的に枝切りされたデンプン |
JPH1180201A (ja) * | 1997-09-01 | 1999-03-26 | Kao Corp | 新規多糖誘導体、その製造方法及びそれを含有する化粧料 |
JP2005519170A (ja) * | 2002-03-08 | 2005-06-30 | ジョージ ウエストン フーズ リミテッド | 架橋されたワキシ小麦デンプン及びこれを含む食品 |
WO2005042587A1 (ja) * | 2003-10-31 | 2005-05-12 | Kowa Co., Ltd. | セルロースiiリン酸エステル及びそれを用いた金属吸着材 |
WO2013146668A1 (ja) * | 2012-03-28 | 2013-10-03 | 国立大学法人岡山大学 | リン酸化多糖の固相合成方法 |
Non-Patent Citations (1)
Title |
---|
JPN6015004841; 沖原 巧 等: '1K-15 リン酸化プルランの合成と生体材料への応用' 2011年日本化学会西日本大会 講演要旨集 , 20111107, p.101, 2011年日本化学会西日本大会実行委員会 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013146669A1 (ja) | 2013-10-03 |
JPWO2013146669A1 (ja) | 2015-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5706579B2 (ja) | リン酸化多糖の製造方法 | |
JP5259700B2 (ja) | 水溶性鉄−炭水化物誘導体錯体、それらの製造、及びそれらを含有している医薬品 | |
JPH0140041B2 (ja) | ||
JP4683988B2 (ja) | 再石灰化作用を有する液体口腔用組成物 | |
JP5907489B2 (ja) | キトサン誘導体から得られるヒドロゲル | |
HU228483B1 (en) | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition | |
JP6143230B2 (ja) | リン酸化多糖の固相合成方法 | |
JP2015529260A (ja) | プロトン化されることができる窒素基または恒久的に正電荷を有する窒素基によって官能化されている、アルテルナンポリサッカロイド。 | |
EP0512599B1 (en) | Phosphorylated polyhydroxy compounds for tartar control | |
EP0323632B1 (en) | Composition for forming calcium phosphate type setting material and process for producing setting material | |
CN106535863A (zh) | 抗结石口腔组合物 | |
JP4200537B2 (ja) | 高いCa可溶化活性を有するリン酸結合澱粉とそのオリゴ糖組成物及びそれらの製造方法 | |
JP2563187B2 (ja) | リン酸カルシウム系硬化体の製造方法 | |
JP2023011207A (ja) | リン酸化多糖の製造方法 | |
CN106673693A (zh) | 一种新型生物陶瓷多孔材料的制备方法 | |
JP4474336B2 (ja) | 口腔チタンインプラント材とその製造方法 | |
JPH0277261A (ja) | リン酸カルシウム系硬化体の製造用複合組成物及び硬化体の製造方法 | |
JPH09175968A (ja) | 口腔用組成物 | |
JP4403140B2 (ja) | 再石灰化促進剤 | |
JP2011057610A (ja) | グリコシド化多価アルコールの製造方法 | |
WO1993001217A1 (de) | Verfahren zur herstellung von stärkeestern für klinische, insbesondere parenterale anwendung | |
HU213872B (en) | Oligo- and polygalacturonate mixed complex, pharmaceutical and food compositions containing them, further process for preparing these compounds | |
JPH02275812A (ja) | リン酸カルシウム系硬化体用液剤及び該液剤を用いた硬化体 | |
JP2002145893A (ja) | リン酸オリゴ糖及びリン酸デキストリンの多価金属塩類組成物並びにそれらの製造方法 | |
JPH01100048A (ja) | リン酸カルシウム系硬化体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20150128 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150210 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5706579 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |